What is Elevance Health's SG&A?

Elevance Health (ELV) reported SG&A of $6.33B in Q1 2026.

How has Elevance Health's SG&A changed year-over-year?

Elevance Health's SG&A increased by 19.4% year-over-year, from $5.3B to $6.33B.

What is the long-term trend for Elevance Health's SG&A?

Over 4 years (2021 to 2025), Elevance Health's SG&A has grown at a 7.2% compound annual growth rate (CAGR), from $15.92B to $20.98B.

Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.

Elevance Health ELV SG&A

SG&A at other companies

HumanaHUM

$4.02B+19.1%

UnitedHealth GroupUNH

$15.39B+13.2%

CenteneCNC

$3.4B+1.3%

Oscar HealthOSCR

$706.23M+46.3%

CignaCI

$3.72B-11.7%

Alignment HealthcareALHC

$121.14M+16.7%

Segments

By segment

See full

Health Benefits$4.88B+1.2%

Corporate & Other$1.12B+279%

Carelon Services$810M+11.6%

CarelonRx$188M-18.3%

Other financials

Income statement

See full

Revenue$50.2B+2.6%

Gross profit$44.7B+1.8%

Net income$1.8B-19.2%

EPS (diluted)$8.00-16.8%

Balance sheet

See full

Cash & equivalents$9.7B+28.8%

Total debt$31.5B+11.0%

Total equity$43.9B+3.3%

Total assets$125.83B+5.1%

Cash flow

See full

Operating cash flow$4.3B+326%

CapEx$235.0M+19.9%

Free cash flow$4.1B+399%

Valuation

See full

Market cap$83.98B-0.6%

Enterprise value$105.82B+1.3%

P/E16×+0.3×

P/S0.4×0.0×

Profitability

See full

Gross margin89.2%+0.6pp

Net margin2.6%-0.6pp

FCF margin3.3%+1.3pp

Returns & leverage

See full

Return on equity12.1%-2.1pp

Debt / equity0.7×+0.1×

Current ratio1.5×0.0×

Where this comes from

Reported directly by Elevance Health in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The official record: Elevance Health’s 10-Q, filed April 22, 2026, on SEC EDGAR. View the filing →

Ask your AI about Elevance Health's sg&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Elevance Health's SG&A?: Elevance Health (ELV) reported SG&A of $6.33B in Q1 2026.
How has Elevance Health's SG&A changed year-over-year?: Elevance Health's SG&A increased by 19.4% year-over-year, from $5.3B to $6.33B.
What is the long-term trend for Elevance Health's SG&A?: Over 4 years (2021 to 2025), Elevance Health's SG&A has grown at a 7.2% compound annual growth rate (CAGR), from $15.92B to $20.98B.
What does SG&A mean?: Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.